Symposium - European Medical Journal

Continue

Symposiums

Oncology
10 Mins
5 Dec 2023

Clinical Perspectives on the Evolution of Non-small Cell Lung Cancer Treatment With Immuno-oncology and ROS1 Tyrosine Kinase Inhibitors

The non-small cell lung cancer (NSCLC) treatment landscape has rapidly evolved over the last two decades. The addition of immuno-oncology…
Oncology
10 Mins
5 Dec 2023

Current and Upcoming Treatment Strategies After CDK4/6 Inhibitors for Patients With ER+/HER2- Advanced Breast Cancer

The latest recommendations and upcoming treatment strategies for patients with oestrogen-receptor positive (ER+), human epidermal growth…
Respiratory
1 Mins
23 Nov 2023

Retracted: Highlights From the European Respiratory Society Congress 2023: Chronic Obstructive Pulmonary Disease and Severe Asthma

The sponsor of the below article (GSK) have requested its retraction in accordance with their internal compliance requirements following…
Dermatology
7 Mins
23 Nov 2023

Bimekizumab 3-Year Efficacy in Patients with Moderate-to-Severe Plaque Psoriasis: Response Maintenance, Re-treatment, and Effect on High-Impact Areas

Psoriasis symptoms can be not only uncomfortable, irritating, and painful, but can also impact several aspects of a patients’ daily life…
Dermatology
8 Mins
23 Nov 2023

Secukinumab for Patients with Moderate-to-Severe Hidradenitis Suppurativa: Post Hoc Analyses of Efficacy Endpoints, Draining Tunnels, Skin Pain, and Work Productivity

Due to the clinical heterogenicity of HS, assessment of disease severity is complex, and over 20 different outcome measures have…
Dermatology
2 Mins
23 Nov 2023

Efficacy and Safety of Upadacitinib in a Phase II Randomised, Double-Blind, Dose-Ranging Study of Adults with Extensive Non-segmental Vitiligo

Vitiligo is an autoimmune skin disorder that causes depigmentation of the skin and/or leukotrichia of the hair, resulting from the…
Respiratory
12 Mins
24 Oct 2023

Balancing Patient Outcomes and Environmental Sustainability in Respiratory Care

This ERS International Congress 2023 review considers prioritising patient outcomes to ensure access to essential inhaled medicines when considering the carbon footprint of inhalers.
Respiratory
10 Mins
24 Oct 2023

Shaping the Future in Rare Lung Diseases: From Imaging to Patient Management

The main objective was to discuss unmet needs in the diagnosis and management of rare lung diseases, with a particular emphasis on alpha…
We’ve noticed you’re accessing
from North/South America.